MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.crmicr.2025.100457

Медицинская библиотека · Current research in microbial sciences · 2025

A T cell-based ubiquitin-mediated mRNA vaccine provides cross-protection against H1N1 and B influenza viruses in mice.

Di Yaxin, Wang Ziliang, Ren Zilin, Huang Haixin, Yang Songhui, Zhang Chenchao, Liang Shibo, Dong Pengyuan, Tai Wanbo, Zhuang Xinyu, Tian Mingyao

СтатьяПеревод пока не подготовлен

Аннотация

Given the persistent antigenic drift of seasonal influenza viruses and the continuous threat of emerging pandemics, there is an urgent necessity to develop novel influenza vaccines capable of conferring broad-spectrum immunity against multiple viral subtypes. CD8+ T cells provide a promising approach to achieving such protection because of their ability to recognize conserved internal antigens. Particularly, the highly cross-reactive internal nucleoprotein of influenza virus demonstrates remarkable efficacy in safeguarding against infection caused by diverse strains. Ubiquitination modification is critical for the differentiation and functionality of CD8+ T cells, thereby modulating the immune response. In this study, three mRNA vaccines were designed using the influenza virus nucleoprotein as an immunogen, including wild-type N protein (WT-N), ubiquitinated wild N protein (Ub-WT-N), and ubiquitinated rearrangement N protein (Ub-Re-N). After immunizing C57BL/6 mice, both WT-N and Ub-WT-N vaccines elicited antibody production, while the Ub-Re-N group exhibited enhanced cellular immune response without inducing antibody production. Subsequently challenged with influenza viruses, the vaccinated mice showed significant protection against mortality and weight loss caused by H1N1 and influenza B strains. Notably, depletion of CD8+ T cells led to a substantial reduction in the protective efficacy of the Ub-Re-N vaccine. In conclusion, the mRNA vaccine encoding Ub-Re-N confers potent defense against influenza virus infection through induction of a robust antigen-specific T cell response.

Для цитирования: Di Yaxin, Wang Ziliang, Ren Zilin, Huang Haixin, Yang Songhui, Zhang Chenchao, Liang Shibo, Dong Pengyuan, Tai Wanbo, Zhuang Xinyu, Tian Mingyao. A T cell-based ubiquitin-mediated mRNA vaccine provides cross-protection against H1N1 and B influenza viruses in mice.. Current research in microbial sciences. 2025. DOI: 10.1016/j.crmicr.2025.100457.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.